Patricia Segales-Rojas1, Leonardo S Lino-Silva2,3, Eduardo Aguilar-Cruz4, Rosa A Salcedo-Hernández4. 1. Surgical Pathology, Instituto Nacional de Cancerología, Mexico City, Mexico. 2. Surgical Pathology, Instituto Nacional de Cancerología, Mexico City, Mexico. saul.lino.sil@gmail.com. 3. Gastrointestinal Pathology Division, Instituto Nacional de Cancerología de México (Mexico's National Cancer Institute, Av. San Fernando # 22, Sección XVI, Tlalpan, CP 14080, Mexico City, Mexico. saul.lino.sil@gmail.com. 4. Surgical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
Abstract
PURPOSE: Gastrointestinal stromal tumors (GIST) have the potential to recur and metastasize. Several prognostic schemes have been developed but none are precise enough and most times the pathologist faces a small biopsy where it is not possible to evaluate the mitotic count. Our aim was to determine the influence of ki67 index and other clinicopathologic characteristics in the recurrence of GIST. METHODS: Forty-three consecutive cases of GIST were studied. The cases presented with non-metastatic disease. We compared the clinicopathologic features of cases with recurrence against those with non-recurrence. The ki67 index was determined by square-millimeters. RESULTS: The median age was 55 years (IQR 45-63), the most frequent site of involvement was the stomach with 21 (48.8%) cases, and the median of tumor diameter was 10 cm (IQR 5.5-17.5). Twenty-six (60.5%) cases were spindle cell, 13 (30.2%) were mixed, and 4 (9.3%) were epithelioid. The median mitosis count for 50 high power fields was 4 (IQR 0-16), while per square millimeter it was 1 (IQR 0-5, range 0-32). The median of the ki67 proliferation index was 5% (IQR 1-20). During the period of study, 11 (25.6%) patients recurred. The only significant differences between patients with GIST with recurrence and without recurrence were the sex and tumor size. CONCLUSION: We did not find an association of the ki67 index with recurrence. The factors associated with recurrence were a high tumor size (> 10 cm) and male sex.
PURPOSE:Gastrointestinal stromal tumors (GIST) have the potential to recur and metastasize. Several prognostic schemes have been developed but none are precise enough and most times the pathologist faces a small biopsy where it is not possible to evaluate the mitotic count. Our aim was to determine the influence of ki67 index and other clinicopathologic characteristics in the recurrence of GIST. METHODS: Forty-three consecutive cases of GIST were studied. The cases presented with non-metastatic disease. We compared the clinicopathologic features of cases with recurrence against those with non-recurrence. The ki67 index was determined by square-millimeters. RESULTS: The median age was 55 years (IQR 45-63), the most frequent site of involvement was the stomach with 21 (48.8%) cases, and the median of tumor diameter was 10 cm (IQR 5.5-17.5). Twenty-six (60.5%) cases were spindle cell, 13 (30.2%) were mixed, and 4 (9.3%) were epithelioid. The median mitosis count for 50 high power fields was 4 (IQR 0-16), while per square millimeter it was 1 (IQR 0-5, range 0-32). The median of the ki67 proliferation index was 5% (IQR 1-20). During the period of study, 11 (25.6%) patients recurred. The only significant differences between patients with GIST with recurrence and without recurrence were the sex and tumor size. CONCLUSION: We did not find an association of the ki67 index with recurrence. The factors associated with recurrence were a high tumor size (> 10 cm) and male sex.
Entities:
Keywords:
Cancer; GIST; Gastrointestinal stromal tumors; Recurrence; ki67 index
Authors: Marcelle R Cerski; Fernanda Pereira; Ursula S Matte; Francine H Oliveira; Felipe L Crusius; Luiz E Waengertner; Alessandro Osvaldt; Fernando Fornari; Luise Meurer Journal: Pathol Res Pract Date: 2011-10-24 Impact factor: 3.250
Authors: Kjetil Søreide; Oddvar M Sandvik; Jon Arne Søreide; Vanja Giljaca; Andrea Jureckova; V Ramesh Bulusu Journal: Cancer Epidemiol Date: 2015-11-24 Impact factor: 2.984
Authors: Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss Journal: Hum Pathol Date: 2002-05 Impact factor: 3.466
Authors: Claire Toquet; Jean Claude Le Néel; Louis Guillou; Karine Renaudin; Antoine Hamy; Marie-Françoise Heymann; Sophie Simon-Valla; Joël Le Borgne; Christine Maugard; Maryse Fiche Journal: Dig Dis Sci Date: 2002-10 Impact factor: 3.199
Authors: Dolores Di Vizio; Francesca Demichelis; Sara Simonetti; Guido Pettinato; Luigi Terracciano; Luigi Tornillo; Michael R Freeman; Luigi Insabato Journal: BMC Cancer Date: 2008-05-13 Impact factor: 4.430
Authors: Klaus Kramer; Uwe Knippschild; Benjamin Mayer; Kira Bögelspacher; Hanno Spatz; Doris Henne-Bruns; Abbas Agaimy; Matthias Schwab; Michael Schmieder Journal: BMC Cancer Date: 2015-02-14 Impact factor: 4.430
Authors: Heli Ylä-Outinen; Niina Loponen; Roope A Kallionpää; Sirkku Peltonen; Juha Peltonen Journal: Mol Genet Genomic Med Date: 2019-08-09 Impact factor: 2.183